Vanda Pharmaceuticals | Umlaufvermögen





Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.79B 137.6M 2025-12
J&J USD 55.62B 1.01B 2025-12
Lexicon Pharmaceuticals USD 145.08M 100.72M 2025-06
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Merck USD 47.56B 10.49B 2025-09
Minerva Neurosciences USD 13.02M 2.53M 2025-09
Moderna USD 6.54B 54M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 3.09B 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Veracyte USD 488.38M 39.15M 2025-12


Vanda Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.